Back to search
FDAFDA · Food and drugs·Recall number Z-1580-2020

LN 3R70-01; software version 2.6.2 and earlier. The software is used with the Alinity i (LN 03R65-01) processing module and the Alinity c (LN 03R67-01) processing module.

Published April 1, 2020 · Recall initiated: January 24, 2020

Summary

FDA records medical device Class II recall Z-1580-2020, published April 1, 2020 and initiated January 24, 2020. Recalling firm: Abbott Gmbh & Co. KG; Status: Terminated; Reported quantity: 2676 units; Lot: LN 3R70-01; software version 2.6.2 and earlier. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Abbott has identified potential performance issues for the Alinity ci -series Software version 2.6.2 and earlier.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Abbott Gmbh & Co. KG
Distributor
Worldwide distribution - US Nationwide distribution in the states of AL, AR, AZ, CA, CO, FL, GA, ID, IL, LA, MA, MD, ME, MI, MN, MC, MS, NC, NJ, NY, OK, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV and countries of Albania, Argentina, Australia, Austria, Bahrain, Bangledesh, Belgium, Bermuda, Bosnia, Botswana, Brazil, Bulgaria, Burkina Faso, Canada, Chile, China, Columbia, Costa Rica, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kuwait, Latvia, Lebanon, Lithuania, Madagascar, Malaysia, Mexico, Namibia, Netherlands, New Caledonia, New Zealand, Norway, Oman, Pakistan, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Trinidad and Tobago Turkey, UEA, UK, Ukraine, Uruguay, Vietnam.
Lot
LN 3R70-01; software version 2.6.2 and earlier.
Risk classification
Class II
Area (FDA)
device
Country
Germany

Related recalls

Questions about this recall

Was LN 3R70-01; software version 2.6.2 and earlier. The software is used with the Alinity i (LN 03R65-01) processing module and the Alinity c (LN 03R67-01) processing module. recalled?

Yes. FDA published recall Z-1580-2020 on April 1, 2020. Reported hazard: Abbott has identified potential performance issues for the Alinity ci -series Software version 2.6.2 and earlier.

What should I do if I have this product?

Voluntary: Firm initiated · Letter